OTCMKTS:VVCIFVIVO Cannabis Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding VIVO Cannabis Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.15 -0.01 (-6.31 %) (As of 04/9/2020 07:08 AM ET) Add Compare Share Today's Range$0.14Now: $0.15▼$0.1550-Day Range$0.12MA: $0.18▼$0.2952-Week Range$0.11Now: $0.15▼$0.72Volume48,124 shsAverage Volume213,877 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartHeadlinesSocial Media VIVO Cannabis Inc. manufactures and distributes medical cannabis. The company was formerly known as ABcann Global Corporation and changed its name to VIVO Cannabis Inc. in August 2018. The company is headquartered in Napanee, Canada.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingVIVO Cannabis has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.70, VIVO Cannabis has a potential upside of 371.4% from its current price of $0.15.Amount of Analyst CoverageVIVO Cannabis has only been the subject of 1 research reports in the past 90 days. Previous Next 3.2 Community Rank Outperform VotesVIVO Cannabis has received 35 “outperform” votes. (Add your “outperform” vote.)Underperform VotesVIVO Cannabis has received 20 “underperform” votes. (Add your “underperform” vote.)Community SentimentVIVO Cannabis has received 63.64% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about VIVO Cannabis and other stocks. Vote “Outperform” if you believe VVCIF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VVCIF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldVIVO Cannabis does not currently pay a dividend.Dividend GrowthVIVO Cannabis does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, VIVO Cannabis insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.3Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.29 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:VVCIF Previous Symbol CUSIPN/A CIKN/A Webhttp://vivocannabis.com/ Phone855-322-2266Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive VVCIF News and Ratings via Email Sign-up to receive the latest news and ratings for VVCIF and its competitors with MarketBeat's FREE daily newsletter. OTC:VVCIF Rates by TradingView VIVO Cannabis (OTCMKTS:VVCIF) Frequently Asked Questions How has VIVO Cannabis' stock been impacted by COVID-19 (Coronavirus)? VIVO Cannabis' stock was trading at $0.1620 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, VVCIF stock has decreased by 8.3% and is now trading at $0.1485. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of VIVO Cannabis? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for VIVO Cannabis in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for VIVO Cannabis. What price target have analysts set for VVCIF? 2 brokers have issued 12 month price targets for VIVO Cannabis' shares. Their forecasts range from $0.70 to $0.70. On average, they expect VIVO Cannabis' share price to reach $0.70 in the next year. This suggests a possible upside of 371.4% from the stock's current price. View analysts' price targets for VIVO Cannabis. Has VIVO Cannabis been receiving favorable news coverage? News coverage about VVCIF stock has been trending very negative recently, InfoTrie reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. VIVO Cannabis earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutVIVO Cannabis. Who are some of VIVO Cannabis' key competitors? Some companies that are related to VIVO Cannabis include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). What other stocks do shareholders of VIVO Cannabis own? Based on aggregate information from My MarketBeat watchlists, some companies that other VIVO Cannabis investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), OrganiGram (OGI), Tilray (TLRY), Curaleaf (CURLF), CannTrust (CTST), Charlotte's Web (CWBHF), Cronos Group (CRON) and HEXO (HEXO). Who are VIVO Cannabis' key executives? VIVO Cannabis' management team includes the following people: Mr. Barry Fishman, CEO & Director (Age 62)Dr. Michael Scott Bumby, Chief Financial Officer (Age 55)Mr. Andrew LaCroix, VP of International Bus. & Gen. Counsel (Age 49)Ms. Ying Guan, VP of Napanee Operations & Sec. (Age 37)Mr. Daniel Laflamme, COO & Director What is VIVO Cannabis' stock symbol? VIVO Cannabis trades on the OTCMKTS under the ticker symbol "VVCIF." How do I buy shares of VIVO Cannabis? Shares of VVCIF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is VIVO Cannabis' stock price today? One share of VVCIF stock can currently be purchased for approximately $0.15. What is VIVO Cannabis' official website? The official website for VIVO Cannabis is http://vivocannabis.com/. How can I contact VIVO Cannabis? The company can be reached via phone at 855-322-2266. This page was last updated on 4/9/2020 by MarketBeat.com StaffFeatured Article: What’s a Black Swan?
